Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125726221 | 12572622 | 1 | I | 20160618 | 20160620 | 20160720 | 20160720 | PER | US-ASTRAZENECA-2016SE68484 | ASTRAZENECA | 11640.00 | DY | F | Y | 66.20000 | KG | 20160720 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125726221 | 12572622 | 1 | PS | ZOLADEX | GOSERELIN ACETATE | 1 | Subcutaneous | 3.6MG UNKNOWN | 19726 | 3.6 | MG | IMPLANT | |||||||
| 125726221 | 12572622 | 2 | C | CELEXA | CITALOPRAM HYDROBROMIDE | 1 | 0 | ||||||||||||
| 125726221 | 12572622 | 3 | C | ESTRADIOL. | ESTRADIOL | 1 | Oral | 1.0MG UNKNOWN | 0 | 1 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125726221 | 12572622 | 1 | Endometriosis |
| 125726221 | 12572622 | 3 | Hot flush |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125726221 | 12572622 | Drug dose omission | |
| 125726221 | 12572622 | Hot flush | |
| 125726221 | 12572622 | Product quality issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125726221 | 12572622 | 1 | 201605 | 0 |